Abstract
G-protein coupled receptors (GPCRs) are important pharmacological targets. Drugs that alter the activity of these receptors can have a therapeutic effect on several diseases, such as cardiovascular, psychological, and immunological diseases. Many drugs were created focusing on the modulation of specific GPCRs, blocking or stimulating their activity. In fact, around 35% of all FDA-approved…